SHC
Get informed when a big investor buys or sells
+ FollowOvervalued by 130.2% based on the discounted cash flow analysis.
| Market cap | $5.09 Billion |
|---|---|
| Enterprise Value | $7.05 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.27 |
| Beta | 1.77 |
| Outstanding Shares | 284,887,000 |
| P/E Ratio | 43.42 |
|---|---|
| PEG | -14.45 |
| Price to Sales | 4.53 |
| Price to Book Ratio | 9.06 |
| Enterprise Value to Revenue | 5.93 |
| Enterprise Value to EBIT | 21.71 |
| Enterprise Value to Net Income | 59 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 3.65 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 2.30%▼ 94.74% |
|---|---|
| Total Invested | $84.77M▼ 97.84% |
| Investors Holding | 76▼ 219.00% |
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...